These medicines, including liraglutide, albiglutide, dulaglutide, and semaglutide, were synthesised using strategic changes of the human GLP-1 molecule to diminish its vulnerability to DPP-4 breakdown
References to specific products, dosing schedules, or clinical protocols in this article are for informational and educational purposes only and do not constitute an endorsement of any specific treatment approach
These may include sweating, irritability, or other mood changes, and fatigue
Research shows several common patterns: Weight Regain Clinical studies show that most people regain some or most of the weight they lost after stopping semaglutide
How to recognize electrolyte deficiency on GLP-1 medications The tricky part about electrolyte deficiency during GLP-1 treatment is that the symptoms look almost identical to normal medication side effects